Old Web
English
Sign In
Acemap
>
Paper
>
Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models
Combined inhibition of SHP2 and ERK enhances anti-tumour effects in preclinical models
2020
Tomoko Smyth
J. Brothwood
L. Fazal
K. Hearn
C Hindley
C. Johnson
M. Jones
N. Kandola
John Lyons
V. Martins
K. Miyadera
S. Muench
J. Munck
Y. Nakatsuru
H. Ochiiwa
H. Saïni
A. Shah
S. Wagner
N.E. Wilsher
Nicola G. Wallis
Keywords:
Cancer research
anti tumour
Chemistry
MAPK/ERK pathway
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]